News from cmc biologics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 08, 2018, 11:00 ET AGC Bioscience, Biomeva, and CMC Biologics to provide services under the brand AGC Biologics

AGC Biologics, a convergence of Asahi Glass Company (AGC) Bioscience, Biomeva GmbH, and CMC Biologics, announced today that effective January 8,...


Jan 08, 2018, 11:00 ET AGC Bioscience, Biomeva und CMC Biologics bieten Dienste unter der Marke AGC Biologics an

AGC Biologics, eine Konvergenz aus Asahi Glass Company (AGC) Bioscience, der Biomeva GmbH und CMC Biologics, gab heute bekannt, dass sie ab 8. Januar ...


Dec 12, 2017, 09:00 ET CMC Biologics anuncia un acuerdo de desarrollo y fabricación con Harpoon Therapeutics

CMC ICOS Biologics, Inc. («CMC Biologics»), líder mundial en fabricación clínica y comercial de proteínas terapéuticas, y Harpoon Therapeutics,...


Dec 12, 2017, 09:00 ET CMC Biologics Announces Development and Manufacturing Agreement with Harpoon Therapeutics

CMC ICOS Biologics, Inc. ("CMC Biologics"), a global leader in clinical and commercial manufacturing of therapeutic proteins, and Harpoon...


Dec 12, 2017, 09:00 ET CMC Biologics verkündet Entwicklungs- und Herstellungsabkommen mit Harpoon Therapeutics

CMC ICOS Biologics, Inc. („CMC Biologics"), weltweiter Führer im Bereich der klinischen und kommerziellen Herstellung therapeutischer Proteine, und...


Dec 12, 2017, 09:00 ET CMC Biologics annonce un accord de développement et production avec Harpoon Therapeutics

CMC ICOS Biologics, Inc. (« CMC Biologics »), leader mondial en fabrication clinique et commerciale de protéines thérapeutiques, et Harpoon...


Dec 20, 2016, 12:11 ET AGC Asahi Glass Signs Agreement to Acquire CMC Biologics

CMC Biologics, a global leader in clinical and commercial manufacturing of monoclonal antibodies, coagulation factors and other therapeutic proteins...


Oct 13, 2016, 02:00 ET Through their PROVEO™ Partnership, CMC Biologics and IDT Biologika Announce the Addition of Cerbios-Pharma and Oncotec Pharma to their Strategic Collaboration for Manufacture of Antibody Drug Conjugates

CMC Biologics A/S, a global leader in clinical and commercial manufacturing of monoclonal antibodies and other therapeutic proteins, and IDT...


Jun 15, 2016, 12:01 ET CMC Biologics als kommerzieller Produzent für das von der FDA zugelassene AFSTYLA® von CSL Behring bestätigt

CMC Biologics, ein Weltmarktführer für die klinische und kommerzielle Produktion von monoklonalen Antikörpern, Gerinnungsfaktoren und anderen...


Jun 15, 2016, 07:53 ET CMC Biologics Cleared for Commercial Manufacture of CSL Behring's FDA-Approved AFSTYLA®

CMC Biologics, a global leader in clinical and commercial manufacturing of monoclonal antibodies, coagulation factors and other therapeutic proteins, ...


Jun 15, 2016, 01:53 ET CMC Biologics est autorisé à produire à des fins commerciales l'AFSTYLA® de CSL Behring agréé par la FDA

CMC Biologics, un leader mondial dans la production d'anticorps monoclonaux, de facteurs de coagulation et d'autres protéines thérapeutiques à des...


Jun 02, 2016, 10:19 ET Toevoeging van een Bioreactor 3PACK™ productie-installatie aan faciliteit Kopenhagen biedt meer flexibele mogelijkheden aan afnemers

CMC Biologics, wereldwijd toonaangevend in klinische en commerciële productie van monoklonale antilichamen, stollingsfactoren en andere...


Jun 02, 2016, 08:28 ET CMC Biologics étend ses capacités de production BPF en Europe

CMC Biologics, leader mondial en fabrication clinique et commerciale d'anticorps monoclonaux, de facteurs de coagulation et autres protéines...


Jun 02, 2016, 06:57 ET CMC Biologics expande la capacidad de fabricación de GMP en Europa

CMC Biologics, un líder global en la fabricación clínica y comercial de anticuerpos monoclonales, factores de coagulación y otras proteínas...


Jun 02, 2016, 06:55 ET CMC Biologics expandiert GMP-Fertigungskapazitäten in Europa

CMC Biologics, ein Weltmarktführer für die klinische und kommerzielle Produktion von monoklonalen Antikörpern, Gerinnungsfaktoren und anderen...


Jun 02, 2016, 06:55 ET CMC Biologics Expands GMP Manufacturing Capacity in Europe

CMC Biologics, a global leader in clinical and commercial manufacturing of monoclonal antibodies, coagulation factors and other therapeutic proteins, ...


Mar 29, 2016, 05:00 ET CMC Biologics Recognized as a Leader in Contract Development and Manufacturing by Customers and the Biopharmaceutical Industry

CMC Biologics, a world leader in contract development and manufacturing of therapeutic proteins, today announced its recognition by Life Science...


Oct 07, 2015, 08:00 ET Governor Inslee's Director of Life Science and Global Health Development, Maura Little, Presides Over CMC Biologics' Ribbon Cutting Ceremony Commemorating the Bioreactor 6Pack™ Manufacturing Facility

CMC Biologics, Inc., a global leader in commercial manufacturing of therapeutic proteins, officially marked the opening of its first-in-class...


Jul 29, 2015, 12:45 ET CMC Biologics et River Vision Development Corporation annoncent un accord de fabrication pour le RV001, anticorps monoclonal destiné au traitement de l'orbitopathie de Graves

CMC Biologics, leader mondial en fabrication clinique et commerciale de protéines thérapeutiques, et River Vision Development Corporation (River...


Jul 29, 2015, 07:13 ET CMC Biologics und River Vision Development Corporation geben Vereinbarung zur Produktion von RV001 bekannt, einem monoklonalen Antikörper für die Behandlung der endokrinen Orbitopathie

CMC Biologics, ein Weltmarktführer für die klinische und kommerzielle Produktion von therapeutischen Proteinen, und River Vision Development...


Jul 29, 2015, 06:00 ET CMC Biologics and River Vision Development Corporation Announce Manufacturing Agreement for RV001, a Monoclonal Antibody to Treat Grave's Orbitopathy

CMC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and River Vision Development Corporation (River...


Jul 29, 2015, 02:12 ET CMC Biologics y River Vision Development Corporation anuncian un acuerdo de fabricación para RV001

CMC Biologics, un líder global en fabricación clínica y comercial de proteínas terapéuticas, y River Vision Development Corporation (River Vision),...


Dec 17, 2014, 07:13 ET CMC Biologics y OncoSynergy llegan a un acuerdo para el desarrollo y fabricación GMP de un fármaco contra el ébola

- CMC Biologics y OncoSynergy llegan a un acuerdo para el desarrollo de procesos acelerados y fabricación GMP de un fármaco investigacional para...


Dec 16, 2014, 09:34 ET CMC Biologics und OncoSynergy unterzeichnen Vereinbarung über die beschleunigte Prozessentwicklung und GMP-Produktion eines Arzneimittelkandidaten zur Bekämpfung von Ebola

CMC Biologics und OncoSynergy unterzeichneten eine Vereinbarung über die beschleunigte Prozessentwicklung und GMP-Produktion von OS2966 – einer...


Dec 16, 2014, 07:00 ET CMC Biologics and OncoSynergy Enter into an Agreement for Accelerated Process Development and GMP Manufacture of an Investigational Drug to Combat Ebola

CMC Biologics and OncoSynergy have entered into an agreement for process development and GMP manufacture of OS2966 – a novel potential treatment for...